ArticleMolecular oncology2026

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.

Kristin Løge Aanestad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.